Finerenone in heart failure: walking a fine line

被引：8
作者：
Naegele, Matthias [1 ]
Hernandez, Adrian F. [2 ,3 ]
Ruschitzka, Frank [1 ]
机构：
[1] Univ Zurich Hosp, Univ Heart Ctr, Cardiol, Zurich, Switzerland
[2] Duke Univ Hlth Syst, Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ Hlth Syst, Div Cardiol, Durham, NC USA
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷 / 27期
关键词：
DISEASE;
D O I：
10.1093/eurheartj/ehw155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2115 / 2117
页数：3
相关论文
共 11 条
  • [1] Use of Aldosterone Antagonists in Heart Failure
    Albert, Nancy M.
    Yancy, Clyde W.
    Liang, Li
    Zhao, Xin
    Hernandez, Adrian F.
    Peterson, Eric D.
    Cannon, Christopher P.
    Fonarow, Gregg C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (15): : 1658 - 1665
  • [2] Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease
    Bramlage, Peter
    Swift, Stephanie L.
    Thoenes, Martin
    Minguet, Joan
    Ferrero, Carmen
    Schmieder, Roland E.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (01) : 28 - 37
  • [3] A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Boehm, Michael
    Gheorghiade, Mihai
    Kober, Lars
    Krum, Henry
    Maggioni, Aldo P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Zannad, Faiez
    Kim, So-Young
    Nowack, Christina
    Palombo, Giovanni
    Kolkhof, Peter
    Kimmeskamp-Kirschbaum, Nina
    Pieper, Alexander
    Pitt, Bertram
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2105 - 2114
  • [4] Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
    Kolkhof, Peter
    Delbeck, Martina
    Kretschmer, Axel
    Steinke, Wolfram
    Hartmann, Elke
    Baerfacker, Lars
    Eitner, Frank
    Albrecht-Kuepper, Barbara
    Schaefer, Stefan
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 64 (01) : 69 - 78
  • [5] ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    McMurray, John J. V.
    Adamopoulos, Stamatis
    Anker, Stefan D.
    Auricchio, Angelo
    Boehm, Michael
    Dickstein, Kenneth
    Falk, Volkmar
    Filippatos, Gerasimos
    Fonseca, Candida
    Angel Gomez-Sanchez, Miguel
    Jaarsma, Tiny
    Kober, Lars
    Lip, Gregory Y. H.
    Maggioni, Aldo Pietro
    Parkhomenko, Alexander
    Pieske, Burkert M.
    Popescu, Bogdan A.
    Ronnevik, Per K.
    Rutten, Frans H.
    Schwitter, Juerg
    Seferovic, Petar
    Stepinska, Janina
    Trindade, Pedro T.
    Voors, Adriaan A.
    Zannad, Faiez
    Zeiher, Andreas
    Bax, Jeroen J.
    Baumgartner, Helmut
    Ceconi, Claudio
    Dean, Veronica
    Deaton, Christi
    Fagard, Robert
    Funck-Brentano, Christian
    Hasdai, David
    Hoes, Arno
    Kirchhof, Paulus
    Knuuti, Juhani
    Kolh, Philippe
    McDonagh, Theresa
    Moulin, Cyril
    Popescu, Bogdan A.
    Reiner, Zeljko
    Sechtem, Udo
    Sirnes, Per Anton
    Tendera, Michal
    Torbicki, Adam
    Vahanian, Alec
    Windecker, Stephan
    McDonagh, Theresa
    Sechtem, Udo
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (14) : 1787 - 1847
  • [6] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    Pitt, B
    Remme, W
    Zannad, F
    Neaton, J
    Martinez, F
    Roniker, B
    Bittman, R
    Hurley, S
    Kleiman, J
    Gatlin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1309 - 1321
  • [7] The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    Pitt, B
    Zannad, F
    Remme, WJ
    Cody, R
    Castaigne, A
    Perez, A
    Palensky, J
    Wittes, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) : 709 - 717
  • [8] Heart failure: the role for mineralocorticoid receptor antagonists
    Pitt, Bertram
    [J]. SWISS MEDICAL WEEKLY, 2014, 144
  • [9] Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
    Pitt, Bertram
    Kober, Lars
    Ponikowski, Piotr
    Gheorghiade, Mihai
    Filippatos, Gerasimos
    Krum, Henry
    Nowack, Christina
    Kolkhof, Peter
    Kim, So-Young
    Zannad, Faiez
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2453 - 2463
  • [10] SELYE H, 1960, P SOC EXP BIOL MED, V104, P212
12